深静脉经导管动脉化用于保肢
本文聚焦深静脉经导管动脉化技术,用于因足部病变无法经动脉重建而面临截肢的严重肢体缺血患者,评估其改善足部氧供的机制与预期 outcomes,并讨论患者筛选与技术评价;该技术尚处早期,早期结果令人鼓舞,持续改进将进一步拓展此类患者的治疗选择。
要点
- 深静脉经导管动脉化为无法动脉重建的严重肢体缺血患者提供保肢可能。
- 该技术通过经皮途径使深静脉动脉化以改善足部氧供。
- 技术尚处早期,早期结果令人鼓舞,仍需持续改进。
核心结论
- 深静脉经导管动脉化尚处早期,早期结果令人鼓舞,持续进步与改进将进一步拓展此类患者的治疗选择。
研究设计与样本
- 本文围绕经皮途径静脉动脉化的近期研究,评估深静脉经导管动脉化改善面临截肢患者足部氧供的机制,并提供患者筛选与技术评价及预期 outcomes。
主要发现
- 深静脉经导管动脉化被评估为改善面临截肢患者足部氧供的机制。
- 本文提供了识别可能从该途径获益患者的方法及对该技术的评价与预期 outcomes。
临床怎么用
- 作者认为该技术尚处早期、早期结果令人鼓舞,持续进步与改进将进一步拓展此类患者的治疗选择。
局限性
- 原文指出该技术尚处早期。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Critical limb-threatening ischemia is the most advanced stage of peripheral arterial disease, and patients with this problem represent a group at very high risk of limb loss. Until recently, patients with severe disease in the foot that was unreconstructable through the arterial system were relegated to treatment with wound care, pain management, and ultimately often faced major amputation. In recent investigations into the use of a percutaneous approach to venous arterialization, transcatheter arterialization of the deep veins has been evaluated as a mechanism to improve oxygen delivery to the foot in patients faced with the prospect of limb loss. Identifying patients who would benefit from this approach and a critical evaluation of the technique are provided along with expected outcomes. While the procedure remains in its infancy, early outcomes are promising, and continued advancement and improvement will further enhance options for these patients.
引用
- Janda L, Clair D. Transcatheter Arterialization of the Deep Veins for Limb Salvage. Ann Vasc Surg. 2024. PMID: 38583763. doi:10.1016/j.avsg.2024.01.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。